Endometriosis in cutaneous scar

N14_ENDOMETRIOSIS_SKIN_SCAR

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N80.6 Hospital discharge: ICD-9 — 6176 Cause of death: ICD-10 — N80.6 Cause of death: ICD-9 — 6176 2 out of 7 registries used, show all original rules.	121
4. Check minimum number of events None	121
5. Include endpoints None	121
6. Filter based on genotype QC (FinnGen only)	121

Control definitions (FinnGen only)

Control exclude: N14_FEMALEGENNONINF

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N80
Name in latin: Endometriosis cicatricis cutaneae

NAME	N14_ENDOMETRIOSIS_SKIN_SCAR
CONTROL_EXCLUDE	N14_FEMALEGENNONINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N806
HD_ICD_9	6176
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N806
COD_ICD_9	6176
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Endometriosis in cutaneous scar based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	700	700	-
Only index persons	683	683	-
Unadjusted period prevalence (%)
Whole population	0.02	0.02	-
Only index persons	0.03	0.03	-
Median age at first event (years)
Whole population	-	36.97	-
Only index persons	-	36.92	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	121	121	-
Unadjusted period prevalence (%)	0.04	0.04	-
Median age at first event (years)	36.40	36.40	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
110: Matched controls
1100

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N80.6

ICD-10 Finland

Endometriosis in cutaneous scar

+∞

127.0

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

+∞

24.9

N80.9

ICD-10 Finland

Endometriosis, unspecified

+∞

21.6

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

+∞

18.2

N80.0

ICD-10 Finland

Endometriosis of uterus

212.7

18.1

N81.6

ICD-10 Finland

Rectocele

198.7

17.0

N80.1

ICD-10 Finland

Endometriosis of ovary

+∞

16.0

6176A

ICD-9 Finland

Endometriosis in scar of skin

+∞

16.0

N97.9

ICD-10 Finland

Female infertility, unspecified

92.8

15.0

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

5.8

14.5

133

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

5.1

14.1

196

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

+∞

13.8

N80.89

ICD-10 Finland

Endometriosis with other specified or multiple localization

+∞

13.8

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

12.1

13.6

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

7.3

12.6

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

22.0

12.0

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

12.7

11.9

TLC00

NOMESCO Finland

Insertion of intrauterine device

11.1

11.7

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

66.6

10.8

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

4.5

10.7

146

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

18.4

10.7

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

5.8

10.6

JAH01

NOMESCO Finland

Laparoscopy

14.1

10.3

N81.1

ICD-10 Finland

Cystocele

60.4

9.8

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

5.7

9.6

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

+∞

9.5

N80.4

ICD-10 Finland

Endometriosis of rectovaginal septum and vagina

+∞

9.5

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

8.2

9.1

N97.8

ICD-10 Finland

Female infertility of other origin

97.1

8.5

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

+∞

8.4

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

8.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.4

8.0

230

LCA06

NOMESCO Finland

Biopsy of endometrium

9.1

7.9

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

48.5

7.8

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

48.5

7.8

N02BE01

ATC

paracetamol; systemic, rectal

5.0

7.8

100

731

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

5.4

7.7

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

5.3

7.5

N95.1

ICD-10 Finland

Menopausal and female climacteric states

+∞

7.4

WX402

NOMESCO Finland

General anaesthesia

4.5

7.2

G03GA01

ATC

chorionic gonadotrophin; parenteral

15.1

7.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.3

6.9

ULC02

NOMESCO Finland

Hysteroscopy

18.1

6.9

G03GA06

ATC

follitropin beta; parenteral

18.1

6.9

N84.0

ICD-10 Finland

Polyp of corpus uteri

42.7

6.8

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

42.7

6.8

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

24.2

6.8

O82.0

ICD-10 Finland

Delivery by elective caesarean section

4.9

6.6

N80

ICD-10 Finland

Endometriosis

73.9

6.5

LAA10

NOMESCO Finland

Percutaneous or transvaginal puncture and recovery of oocyte

+∞

6.3

N80.5

ICD-10 Finland

Endometriosis of intestine

+∞

6.3

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

+∞

6.3

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

7.5

6.3

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

13.6

6.2

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

13.6

6.2

B02AA02

ATC

tranexamic acid; systemic

4.0

6.1

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

5.16

13.13

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

358

3.16

8.87

2.0

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

401

2.77

6.98

3.9

3.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

6.32

5.72

1.9

1.3

pmol/l

40.3

84.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3.86

5.09

2.8

3.7

u/ml

28.6

69.8

0.41

(3044640) Blood type and Crossmatch panel - Blood

246

2.40

4.90

2.2

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.85

4.06

1.4

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

213

2.14

3.46

1.9

1.7

mg/l

0.7

0.8

0.06

159

(3032080) INR in Blood by Coagulation assay

237

2.10

3.45

6.2

4.7

inr

1.0

1.1

0.59

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

184

2.18

3.37

2.0

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

114

999

3.44

3.36

12.9

9.0

mg/l

20.0

19.3

0.09

715

(3026008) Bacteria identified in Urine by Culture

231

2.02

3.03

2.0

2.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2.50

2.95

1.3

1.4

iu/l

48.5

25.0

0.93

(3013512) EKG study

178

2.08

2.93

2.8

2.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

105

2.34

2.91

2.5

umol/l

13.6

14.8

0.33

(3000850) Epithelial cells [#/volume] in Urine

135

2.18

2.83

3.4

2.2

e6/l

6.9

7.8

0.16

117

(4010399)

2.85

2.72

1.4

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

639

1.88

2.64

5.0

3.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

4.00

2.51

3.1

1.5

13.4

13.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

666

1.78

2.25

2.8

2.5

u/l

34.9

31.3

0.24

632

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

104

908

2.03

1.99

11.2

7.7

ml/min/173m2

91.8

91.0

0.17

710

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

834

1.82

1.87

4.2

3.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

4.30

1.84

1.4

1.1

—

(3044889) 12 lead EKG panel

587

1.61

1.77

2.7

2.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

659

1.63

1.74

8.6

6.3

u/l

67.2

73.1

1.20

629

(3021589) Normoblasts [#/volume] in Blood

407

1.59

1.69

13.1

6.4

e9/l

0.0

0.62

325

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

247

1.65

1.64

3.8

2.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

239

1.65

1.62

5.0

2.3

—

(3015736) pH of Urine

355

1.58

1.62

4.1

2.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

439

1.56

1.61

6.9

3.9

estimate

0.0

0.49

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

337

1.59

1.61

5.0

2.9

—

(3025941) Bacteria identified in Stool by Culture

2.16

1.61

1.0

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

442

1.55

5.1

2.8

estimate

0.0

0.00

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

295

1.59

1.54

2.2

1.8

pmol/l

95.0

93.5

0.08

173

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.69

1.54

4.0

2.2

0.7

0.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.95

1.52

2.8

43.3

40.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

261

1.60

1.50

1.4

1.2

u/ml

0.6

1.4

0.59

(3018095) Leukocytes [#/volume] in Urine

271

1.59

1.47

4.6

2.9

e6/l

62.1

65.1

0.02

164

(3022145) Colonoscopy Study observation

2.01

1.46

1.6

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.05

1.44

3.5

2.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

2.35

1.43

3.8

2.5

kpa

4.7

4.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1.87

1.37

1.1

1.3

iu/ml

276.5

90.8

—

(36304419) Bacteria [Presence] in Urine

198

1.61

1.34

4.1

2.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.58

1.32

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

157

1.66

1.30

3.5

3.2

—

(3009261) Glucose [Presence] in Urine by Test strip

446

1.48

1.28

5.2

2.9

estimate

0.0

0.00

(3013826) Glucose [Moles/volume] in Serum or Plasma

456

1.47

1.27

4.6

3.8

mmol/l

6.5

6.3

0.29

405

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

105

955

1.75

1.27

4.0

3.4

mmol/l

1.5

1.6

0.45

100

912

(3002032) Base excess in Venous blood by calculation

2.13

1.26

3.5

4.0

mmol/l

0.6

2.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.24

1.24

1.4

1.8

—

(4306422)

2.70

1.23

1.0

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2.70

1.23

1.0

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

238

1.53

1.20

1.5

1.2

g/l

2.0

2.1

0.18

152

(3012544) pH of Venous blood

2.09

1.20

3.5

3.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.41

1.14

4.0

2.2

0.9

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

232

1.52

1.14

5.4

3.2

estimate

0.0

0.49

(40761536) Microorganisms panel - Urine sediment

1.91

1.13

5.8

2.5

—

(36660697) Celiac disease serology panel - Serum

1.75

1.13

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.02

1.11

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

122

1.66

1.11

1.5

1.6

—

(3000492) Spirometry study

1.80

1.10

1.9

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2.44

1.10

1.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

400

1.43

1.08

4.9

5.7

umol/l

10.7

9.2

0.62

380

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2.19

1.07

2.1

1.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

2.33

1.04

1.8

1.2

u/ml

261.7

139.7

—

(40761511) CBC panel - Blood by Automated count

113

1069

1.86

1.01

12.8

8.5

—

(3019198) Lymphocytes [#/volume] in Blood

481

1.40

1.01

7.2

5.3

e9/l

1.8

2.1

0.96

428

(1761868) Lipid panel - Serum or Plasma

395

1.40

1.00

2.7

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

152

1.55

0.97

2.4

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

179

1.50

0.94

1.8

2.0

—

(40761535) Cells panel - Urine sediment

1.82

0.93

3.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

200

1.45

0.86

1.8

2.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

282

1.39

0.85

1.8

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.92

0.83

1.3

1.9

—

(3006315) Basophils [#/volume] in Blood

464

1.34

0.82

7.4

5.5

e9/l

0.0

0.19

404

(3042936) Bacteria identified in Isolate by Culture

100

1.57

0.77

1.3

1.7

—

(40768797) Stomach Pathology biopsy report

100

1.57

0.77

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

2.04

0.73

1.6

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2.04

0.73

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

235

1.37

0.71

3.9

4.4

—

(3001604) Monocytes [#/volume] in Blood

462

1.30

0.71

7.5

5.4

e9/l

0.5

0.86

405

(3001019) Free T4 and TSH panel - Serum or Plasma

0.51

0.70

4.6

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.55

0.66

1.2

1.3

—

(3013115) Eosinophils [#/volume] in Blood

485

1.29

0.66

7.5

6.2

e9/l

0.2

0.49

427

(3013650) Neutrophils [#/volume] in Blood by Automated count

535

1.28

0.65

9.5

8.8

e9/l

3.8

4.0

0.43

468

(3004588) Protein electrophoresis panel - Serum or Plasma

1.75

0.64

1.2

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

105

1.49

0.63

2.5

e6/l

4.4

3.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

105

1.49

0.63

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.68

0.63

1.5

2.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.50

0.62

1.8

1.9

—

(40768443) Skin Pathology biopsy report

1.69

0.62

1.0

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

919

1.35

0.59

3.8

3.0

mmol/l

1.2

1.1

0.09

871

(21494755) Public health laboratory ask at order entry panel

159

0.66

0.59

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.75

0.58

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.75

0.58

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.70

0.57

1.3

—

(3019225) pH of Specimen

1.57

0.56

1.2

2.4

—

(3011288) Drugs identified in Urine by Screen method

1.61

0.55

1.2

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.51

0.53

2.9

2.2

nmol/l

373.4

386.6

0.12

(3002385) Erythrocyte distribution width [Ratio]

871

1.29

0.52

16.3

12.0

13.3

13.5

0.68

858

(3011397) Hemoglobin [Presence] in Urine by Test strip

219

1.30

0.51

4.0

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

314

1.26

0.49

1.5

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

220

1.29

0.49

1.2

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.51

0.48

1.2

—

(3012516) Albumin [Mass/volume] in Urine

184

1.31

0.48

2.5

2.9

mg/l

18.8

52.0

1.20

113

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

251

1.26

0.45

2.0

2.8

ng/l

9.9

15.8

1.54

123

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.40

0.45

1.1

1.5

—

(42870588) Differential panel, method unspecified - Blood

261

1.25

0.44

8.4

5.9

—

(3019150) Specific gravity of Urine by Refractometry

205

1.28

0.44

3.8

3.3

kg/l

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

141

1.32

0.43

1.3

1.6

—

(3003694) ABO and Rh group [Type] in Blood

311

1.22

0.41

1.7

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.49

0.41

2.0

2.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.33

0.40

1.1

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1.39

0.39

1.2

—

26.8

—

(3000494) Fungus identified in Specimen by Culture

1.37

0.39

1.4

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.42

0.38

1.7

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

191

1.25

0.37

3.4

3.5

mg/mmol

2.7

10.5

1.42

115

(1002224) Polysomnography panel

1.42

0.35

1.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

118

1.31

0.35

2.5

2.4

e6/l

0.3

1.1

—

(3000991) Gas panel - Venous blood

1.34

0.31

5.4

5.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

159

1.23

0.29

1.4

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

171

0.79

0.28

1.5

1.3

u/ml

1.5

9.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.27

0.28

1.9

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.23

0.27

1.9

1.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1.33

0.27

2.5

2.1

—

21.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.66

0.27

1.0

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.27

0.26

1.6

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.25

0.26

1.1

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

266

1.17

0.26

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.37

0.24

7.2

4.7

mmol/l

23.0

25.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.37

0.24

4.2

6.7

88.3

94.9

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.33

0.23

4.2

6.6

1.0

0.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.33

0.23

4.2

6.6

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.29

0.23

1.8

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

136

1.20

0.21

2.1

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.21

0.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.13

0.15

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.13

0.15

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.13

0.15

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.13

0.15

1.2

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

269

1.10

0.13

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.17

0.12

4.0

5.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.07

0.09

1.6

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

134

0.88

0.09

2.3

3.3

ng/l

62.4

203.0

—

(4035726)

1.12

0.09

1.3

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.10

0.09

2.2

1.7

—

(3027944) Amphetamines [Presence] in Urine

0.83

0.08

1.4

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.09

0.07

1.3

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

959

1.06

0.04

14.3

11.2

39.4

39.7

0.14

787

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

111

1.09

0.04

1.4

1.7

—

(40758558) Short blood count panel - Blood

230

0.95

0.04

7.9

7.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

174

0.97

0.00

1.5

1.3

iu/ml

12.4

32.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

131

0.99

0.00

1.8

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

233

0.98

0.00

2.0

1.6

mmol/l

1.1

1.3

1.38

218

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

0.00

0.0

6.1

—

0.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.2

—

(3036603) Volume of Urine

0.00

0.0

1.8

—

(4281824)

0.00

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

3.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.0

1.1

—

(3044941) Cell count panel - Synovial fluid

0.00

0.0

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

3.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

0.0

2.0

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

0.00

0.0

1.1

—

24.4

—

(3016879) Cocaine [Presence] in Urine

0.89

0.00

1.4

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.0

12.0

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

0.00

0.0

2.0

—

6.3

—

(4198724)

0.00

0.0

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

7.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.00

0.0

4.0

—

11.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

0.0

3.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.96

0.00

1.4

1.2

—

(3028433) Virus identified in Specimen by Culture

0.00

0.0

1.0

—

(3021788) Differential panel - Synovial fluid

0.00

0.0

2.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.00

0.0

4.0

—

14.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_ENDOMETRIOSIS_SKIN_SCAR and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_ENDOMETRIOSIS_SKIN_SCAR.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: N14_ENDOMETRIOSIS_SKIN_SCAR – Endometriosis in cutaneous scar

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Endometriosis in cutaneous scar

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints